Catherine Ramsey
Stock Analyst at Baird
(3.03)
# 1,087
Out of 4,829 analysts
49
Total ratings
35.14%
Success rate
4.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WAT Waters | Maintains: Outperform | $355 → $374 | $366.67 | +2.00% | 10 | May 7, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $32.95 | +33.54% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $98.50 | +26.90% | 5 | Apr 29, 2025 | |
ILMN Illumina | Maintains: Neutral | $127 → $90 | $81.57 | +10.33% | 5 | Mar 5, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $157.29 | +19.52% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $17.04 | +117.14% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $432.59 | +53.73% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $115.55 | +38.47% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $53.40 | +40.45% | 1 | Aug 3, 2022 |
Waters
May 7, 2025
Maintains: Outperform
Price Target: $355 → $374
Current: $366.67
Upside: +2.00%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $32.95
Upside: +33.54%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $98.50
Upside: +26.90%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $81.57
Upside: +10.33%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $157.29
Upside: +19.52%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $17.04
Upside: +117.14%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $432.59
Upside: +53.73%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $115.55
Upside: +38.47%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $53.40
Upside: +40.45%